StockNews.com Initiates Coverage on Bellerophon Therapeutics (NASDAQ:BLPH)

StockNews.com started coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research note released on Tuesday. The brokerage issued a hold rating on the biotechnology company’s stock. Bellerophon Therapeutics Price Performance BLPH opened at $0.06 on Tuesday. The company’s 50-day moving average is $0.04 and its 200 day moving average is $0.28. […]

Leave a Reply

Your email address will not be published.

Previous post CalAmp (NASDAQ:CAMP) Coverage Initiated by Analysts at StockNews.com
Next post Piper Sandler Reiterates “Neutral” Rating for Bank First (NASDAQ:BFC)